Dao-zi Jiang

Recommendations for standardized management of CML patients in the core epidemic area of COVID-19(Multi-center survey results in Hubei Province, China)

Q. Li, D. Wang, X. Zuo, 2020, medRxiv.

The First Report of the Prevalence of COVID-19 in Chronic Myelogenous Leukemia Patients in the Core Epidemic Area of China: A Multicentre, Cross-Sectional Survey

L. Meng, Youlin Zhao, Zhuangzhi Yang, 2020 .

COVID-19 in persons with chronic myeloid leukaemia

Q. Jiang, Zhuangzhi Yang, Hongxiang Wang, 2020, Leukemia.

Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia

Jian Huang, J. Jin, J Jin, 2006, Leukemia.